10F9G2-mIgG2a-PGLALA

10F9G2 monoclonal antibody can bind to mouse PD-L1 (programmed death ligand 1). Programmed cell death 1 ligand 1 (PD-L1), also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1), is encoded by the CD274 gene. Recent years, a total of 5 PD-1/PD-L1 antibody drugs have been approved, including 2 PD-1 inhibitors and 3 PD-L1 inhibitors, with indications involving non-small cell lung cancer, gastric cancer, melanoma kidney cancer, etc., and new indications will be approved one after another. 10F9G2 antibodies have been shown to block the interaction between PD-L1 and PD-1 and PD-L1 and B7-1 (CD80), promising for cancer treatment.